140 related articles for article (PubMed ID: 19350558)
1. Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice.
Lim DS; Kang MS; Jeong JA; Bae YS
Eur J Immunol; 2009 May; 39(5):1334-43. PubMed ID: 19350558
[TBL] [Abstract][Full Text] [Related]
2. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
3. IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3+ regulatory T cells.
Srivastava RK; Tomar GB; Barhanpurkar AP; Gupta N; Pote ST; Mishra GC; Wani MR
J Immunol; 2011 Feb; 186(4):2262-72. PubMed ID: 21242512
[TBL] [Abstract][Full Text] [Related]
4. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.
Popov I; Li M; Zheng X; San H; Zhang X; Ichim TE; Suzuki M; Feng B; Vladau C; Zhong R; Garcia B; Strejan G; Inman RD; Min WP
Arthritis Res Ther; 2006; 8(5):R141. PubMed ID: 16911769
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
6. NFKBIL1 confers resistance to experimental autoimmune arthritis through the regulation of dendritic cell functions.
Chiba T; Matsuzaka Y; Warita T; Sugoh T; Miyashita K; Tajima A; Nakamura M; Inoko H; Sato T; Kimura M
Scand J Immunol; 2011 May; 73(5):478-85. PubMed ID: 21284685
[TBL] [Abstract][Full Text] [Related]
7. Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg.
Biollaz G; Bernasconi L; Cretton C; Püntener U; Frei K; Fontana A; Suter T
Eur J Immunol; 2009 May; 39(5):1323-33. PubMed ID: 19337997
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion.
Eljaafari A; Li YP; Miossec P
J Immunol; 2009 Sep; 183(5):2932-45. PubMed ID: 19696431
[TBL] [Abstract][Full Text] [Related]
9. Effect of sinomenine on collagen-induced arthritis in mice.
Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
Autoimmunity; 2007 Nov; 40(7):532-9. PubMed ID: 17966044
[TBL] [Abstract][Full Text] [Related]
10. A novel recombinant peptide containing only two T-cell tolerance epitopes of chicken type II collagen that suppresses collagen-induced arthritis.
Xi C; Tan L; Sun Y; Liang F; Liu N; Xue H; Luo Y; Yuan F; Sun Y; Xi Y
Mol Immunol; 2009 Feb; 46(4):729-37. PubMed ID: 19041137
[TBL] [Abstract][Full Text] [Related]
11. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis.
Tada Y; Koarada S; Morito F; Mitamura M; Inoue H; Suematsu R; Ohta A; Miyake K; Nagasawa K
Arthritis Res Ther; 2008; 10(5):R121. PubMed ID: 18847495
[TBL] [Abstract][Full Text] [Related]
13. Tolerogenic splenic IDO (+) dendritic cells from the mice treated with induced-Treg cells suppress collagen-induced arthritis.
Yang J; Yang Y; Fan H; Zou H
J Immunol Res; 2014; 2014():831054. PubMed ID: 25405209
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
[TBL] [Abstract][Full Text] [Related]
15. Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cells.
Carranza F; Falcón CR; Nuñez N; Knubel C; Correa SG; Bianco I; Maccioni M; Fretes R; Triquell MF; Motrán CC; Cervi L
PLoS One; 2012; 7(7):e40356. PubMed ID: 22848374
[TBL] [Abstract][Full Text] [Related]
16. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.
Arikawa T; Watanabe K; Seki M; Matsukawa A; Oomizu S; Sakata KM; Sakata A; Ueno M; Saita N; Niki T; Yamauchi A; Hirashima M
Clin Immunol; 2009 Dec; 133(3):382-92. PubMed ID: 19800850
[TBL] [Abstract][Full Text] [Related]
17. Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice.
Abe K; Wechs S; Kalaydjiev S; Franz TJ; Busch DH; Fuchs H; Soewarto D; Behrendt H; Wagner S; Jakob T; Hrabé de Angelis M
Rheumatology (Oxford); 2008 Mar; 47(3):292-300. PubMed ID: 18276736
[TBL] [Abstract][Full Text] [Related]
18. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell subsets: their roles in rheumatoid arthritis.
Lebre MC; Tak PP
Acta Reumatol Port; 2008; 33(1):35-45. PubMed ID: 18344920
[TBL] [Abstract][Full Text] [Related]
20. DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice.
Park JE; Jang J; Choi JH; Kang MS; Woo YJ; Seong YR; Choi CB; Lee HS; Bae SC; Bae YS
J Immunol Res; 2015; 2015():834085. PubMed ID: 26221616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
